Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Cash Flow-to-Debt Ratio
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Cash Flow-to-Debt Ratio of -0.18x as of September 2025, meaning its operating cash flow of CN¥-8.22 Million could theoretically repay 0% of its total liabilities (CN¥45.34 Million) in one year. Explore long-term investment intensity of Qinghai Spring Medicinal Resources Techn to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Qinghai Spring Medicinal Resources Technology Co Ltd across 27 annual periods. Also explore Qinghai Spring Medicinal Resources Techn asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Qinghai Spring Medicinal Resources Technology Co Ltd. For market capitalisation and broader financial context, see Qinghai Spring Medicinal Resources Techn (600381) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.59x | CN¥-26.41 Million | CN¥44.87 Million | ▼ -193.1% |
| 2024 | 0.63x | CN¥80.97 Million | CN¥128.02 Million | ▲ +143.3% |
| 2023 | 0.26x | CN¥23.92 Million | CN¥91.99 Million | ▲ +121.5% |
| 2022 | -1.21x | CN¥-31.82 Million | CN¥26.30 Million | ▲ +47.7% |
| 2021 | -2.31x | CN¥-63.93 Million | CN¥27.64 Million | ▼ -306.8% |
| 2020 | -0.57x | CN¥-77.95 Million | CN¥137.08 Million | ▲ +95.2% |
| 2019 | -11.74x | CN¥-236.30 Million | CN¥20.14 Million | ▼ -236.1% |
| 2018 | -3.49x | CN¥-183.97 Million | CN¥52.68 Million | ▼ -514.2% |
| 2017 | 0.84x | CN¥95.74 Million | CN¥113.56 Million | ▼ -49.4% |
| 2016 | 1.67x | CN¥344.99 Million | CN¥206.95 Million | ▼ -29.0% |
| 2015 | 2.35x | CN¥832.17 Million | CN¥354.60 Million | ▲ +3049.9% |
| 2014 | -0.08x | CN¥-89.64 Million | CN¥1.13 Billion | ▼ -307.5% |
| 2013 | -0.02x | CN¥-28.09 Million | CN¥1.44 Billion | ▲ +94.7% |
| 2012 | -0.37x | CN¥-701.18 Million | CN¥1.90 Billion | ▼ -338.9% |
| 2011 | 0.15x | CN¥249.98 Million | CN¥1.62 Billion | ▲ +102.9% |
| 2010 | 0.08x | CN¥71.47 Million | CN¥938.58 Million | ▲ +2.2% |
| 2009 | 0.07x | CN¥39.16 Million | CN¥525.60 Million | ▲ +110.7% |
| 2008 | 0.04x | CN¥20.83 Million | CN¥589.02 Million | ▲ +257.7% |
| 2007 | 0.01x | CN¥7.00 Million | CN¥707.61 Million | ▼ -60.4% |
| 2006 | 0.02x | CN¥21.57 Million | CN¥863.38 Million | ▼ -83.9% |
| 2005 | 0.16x | CN¥162.12 Million | CN¥1.05 Billion | ▲ +461.1% |
| 2004 | 0.03x | CN¥33.83 Million | CN¥1.22 Billion | ▲ +1430.8% |
| 2003 | 0.00x | CN¥1.43 Million | CN¥789.85 Million | ▼ -95.2% |
| 2002 | 0.04x | CN¥15.54 Million | CN¥415.90 Million | ▲ +193.0% |
| 2001 | -0.04x | CN¥-10.64 Million | CN¥264.94 Million | ▼ -267.0% |
| 2000 | 0.02x | CN¥4.52 Million | CN¥187.91 Million | ▼ -95.6% |
| 1999 | 0.55x | CN¥70.28 Million | CN¥128.04 Million | — |